Samalin Investment Counsel’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$703K Sell
1,940
-18
-0.9% -$6.16K 0.22% 113
2026
Q1
$689K Sell
1,958
-282
-13% -$101K 0.24% 122
2025
Q4
$733K Buy
2,240
+124
+6% +$39.3K 0.26% 112
2025
Q3
$597K Sell
2,116
-48
-2% -$13.9K 0.21% 145
2025
Q2
$604K Sell
2,164
-65
-3% -$18.4K 0.23% 131
2025
Q1
$695K Sell
2,229
-940
-30% -$278K 0.28% 104
2024
Q4
$826K Sell
3,169
-1,015
-24% -$301K 0.35% 82
2024
Q3
$1.35M Buy
4,184
+2,044
+96% +$669K 0.59% 40
2024
Q2
$669K Buy
2,140
+154
+8% +$45.2K 0.31% 96
2024
Q1
$565K Sell
1,986
-310
-14% -$90.7K 0.27% 117
2023
Q4
$662K Sell
2,296
-35
-2% -$9.54K 0.33% 86
2023
Q3
$626K Buy
2,331
+172
+8% +$42.9K 0.36% 85
2023
Q2
$479K Buy
2,159
+653
+43% +$152K 0.26% 120
2023
Q1
$364K Buy
1,506
+20
+1% +$4.91K 0.22% 134
2022
Q4
$390K Sell
1,486
-165
-10% -$44.2K 0.25% 127
2022
Q3
$372K Buy
1,651
+253
+18% +$61.3K 0.27% 111
2022
Q2
$340K Buy
1,398
+47
+3% +$11.5K 0.24% 131
2022
Q1
$327K Buy
1,351
+419
+45% +$96.3K 0.2% 158
2021
Q4
$210K Buy
+932
New +$197K 0.13% 220
2021
Q3
Sell
-883
Closed -$215K 239
2021
Q2
$215K Buy
883
+20
+2% +$4.92K 0.14% 218
2021
Q1
$214K Buy
+863
New +$206K 0.14% 210
2020
Q4
Sell
-854
Closed -$217K 224
2020
Q3
$217K Sell
854
-49
-5% -$12.1K 0.19% 161
2020
Q2
$213K Buy
+903
New +$206K 0.22% 137
2020
Q1
Sell
-917
Closed -$221K 159
2019
Q4
$221K Buy
+917
New +$202K 0.19% 140

Other funds holding AMGN

Samalin Investment Counsel's AMGN Position: Q2 2026 in Review

Samalin Investment Counsel reduced its Amgen (AMGN) stake by 0.92% in Q2 2026, selling an estimated $6.16K and leaving 1,940 shares worth $703K. The position accounts for 0.22% of the portfolio, ranked #113.

Samalin Investment Counsel first reported a position in AMGN in Q4 2019 and has held it in 24 quarters since. The position peaked at $1.35M in Q3 2024. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Samalin Investment Counsel held 1,940 shares of Amgen worth $703K as of Q2 2026.
  • Samalin Investment Counsel sold 18 Amgen shares in Q2 2026, an estimated $6.16K.
  • Amgen made up 0.22% of Samalin Investment Counsel's portfolio in Q2 2026, its #113 holding.
  • Samalin Investment Counsel first reported a position in Amgen in Q4 2019 and has held it in 24 quarters since.
  • Samalin Investment Counsel's Amgen position peaked at $1.35M in Q3 2024.
  • 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Samalin Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.